Article | Published:

Mosaic and polymorphic imprinting of the WT1 gene in humans

Abstract

We have examined the imprinting of the Wilms' tumour suppressor gene (WT1) in human tissues. We confirm that WT1 is biallelically expressed in the kidney, however, in five of nine preterm placentae WT1 was expressed largely or exclusively from the maternal allele. Monoallelic expression of WT1 was also found in two fetal brains. These data demonstrate that WT1 can undergo tissue specific imprinting. Furthermore, because monoallelic expression of WT1 was not found in all placentae examined, WT1 imprinting may be genetically polymorphic within the human population.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hall, J.G. Genomic imprinting: Review and relevance to human diseases. Am. J. hum. Genet. 46, 857–873 (1990).

  2. 2

    Ogawa, O. et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749–751 (1993).

  3. 3

    Rainier, S. et al. Relaxation of imprinted genes in human cancer. Nature 362, 747–749 (1993).

  4. 4

    Wagstaff, J. et al. Maternal but not paternal transmission of 15q11–13-linked nondeletion Angelman syndrome leads to phenotypic expression. Nature Genet. 1, 291–294 (1992).

  5. 5

    Özçelik, T. et al. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genet. 2, 265–269 (1992).

  6. 6

    DeChiara, T.M., Robertson, E.J. & Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849–859 (1991).

  7. 7

    Ohlsson, R. et al. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet. 4, 94–97 (1993).

  8. 8

    Giannoukakis, N., Deal, C., Paquette, J., Goodyer, C.G. & Polychronakos, C. Parental genomic imprinting of the human IGF2 gene. Nature Genet. 4, 98–101 (1993).

  9. 9

    Barlow, D.P., Stöger, R., Herrmann, B.G., Saito, K. & Sohweifer, N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349, 84–87 (1991).

  10. 10

    Drummond, I.A. et al. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257, 674–678 (1992).

  11. 11

    Haig, D. & Graham, C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64, 1045–1046 (1991).

  12. 12

    Pelletier, J. et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67, 437–447 (1991).

  13. 13

    Bruening, W. et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet. 1, 144–148 (1992).

  14. 14

    Little, M.H. et al. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in adominant-negative fashion. Hum. molec. Genet. 2, 259–264 (1993).

  15. 15

    Van Heyningen, V. & Hastie, N.D. Wilms' tumour: reconciling genetics and biology. Trends Genet. 8, 16–21 (1992).

  16. 16

    Riccardi, V.M. et al. The aniridia-Wilms tumor association: The critical role of chromosome band 11p13. Cancer Genet. Cytogenet. 2, 131–137 (1980).

  17. 17

    Riccardi, V.M. et al. Wilms tumor with aniridia/iris dysplasia and apparently normal chromosomes. J. Pediatr. 100, 574–577 (1982).

  18. 18

    Jadresic, L. et al. Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J. Pediatr. 117, 717–725 (1990).

  19. 19

    Zhang, Y., Tycko, B. Monoallelic expression of the human H19 gene. Nature Genet. 1, 40–44 (1992).

  20. 20

    Little, M.H. et al. Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogens 7, 635–641 (1992).

  21. 21

    Gessler, M., König, A. & Bruns, G.A.P. The genomic organization and expression of the WT1 gene. Genomics 12, 807–813 (1992).

  22. 22

    Hoban, P.R. & Kelsey, A.M. HinfI polymorphism within the 3′ untranslated region of the candidate Wilms tumour gene. Nucl. Acids Res. 19, 1164 (1990).

  23. 23

    Barlow, D.P. Methylation and imprinting: From host defense to gene regulation? Science 260, 309–310 (1993).

  24. 24

    Sapienza, C. Genome imprinting, cellular mosaicism and carcinogenesis. Molec. Carcinog. 3, 118–121 (1990).

  25. 25

    Weksberg, R., Shen, D.R., Fei, Y.L., Song, Q.L. & Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Biedemann syndrome. Nature Genet. 5, 143–149 (1993).

  26. 26

    Ogawa, O. et al. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nature Genet. 5, 408–412 (1993).

  27. 27

    Huff, V., Meadows, A., Riccardi, V.M., Strong, L.C., Saunders, G.F. Parental origin of de novo constitutional deletions of chromosomal band 11p13. Am. J. hum. Genet. 47, 155–160 (1990).

  28. 28

    Kreidberg, J.A. et al. WT-1 is required for early kidney development. Cell 74, 679–691 (1993).

  29. 29

    Hill, R.E. et al. Mouse Small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522–525 (1991).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading